INVESTING IN OUR COMMUNITIES

GlaxoSmithKline is designated a Caring Company by Imagine Canada, a national organization that supports Canada's charities, nonprofit organizations and community-minded businesses. As a Caring Company, GlaxoSmithKline annually donates a minimum of one per cent of pre-tax profits through The GlaxoSmithKline Foundation and other channels.

 

THE GLAXOSMITHKLINE FOUNDATION

• The GlaxoSmithKline Foundation was established in Canada in 1989, and is dedicated to enhancing the quality of life for Canadians.
  
  

• The Foundation supports and works with registered Canadian charities in the areas of health care and health promotion, science education, HIV/AIDS, and hospice palliative care.
  
  

• GlaxoSmithKline employees chose hospice palliative care as the company’s “cause of choice,” in 1997, and GlaxoSmithKline and The Foundation direct substantial energy and resources toward this cause.
  
  

• The GlaxoSmithKline Foundation, in conjunction with the Canadian Hospice Palliative Care Association and hospice palliative care organizations across the country, launched Living Lessons®.  Established in 1998, the national campaign aims to raise awareness of, and support for, hospice palliative care services.
  
  

• Living Lessons® began as a public awareness campaign and has now evolved to consist of a number of resources for caregivers and health-care professionals such as:

~    A physician awareness publication to assist health-care providers in understanding and communicating with patients facing a terminal illness

~    A Guide for Caregivers to assist the more than three million Canadians who will provide care for loved ones facing the end of life

~    The You are not Alone brochure to provide information and answers to important questions to those confronted with a life-threatening illness

~    A Web site (www.living-lessons.org) and toll-free number (1-877-203-INFO) to help Canadians address issues concerning end-of-life care.
 

CORPORATE SOCIAL RESPONSIBILITY

• GlaxoSmithKline is a leading contributor to Health Partners International of Canada (HPIC). HPIC is a charitable organization that provides free medications, medical supplies and vaccines, donated by Canada’s health industry, including research-based pharmaceutical companies, to Canadian doctors and Non-Governmental Organizations working in the developing world and to countries that are in need of medical aid. Since 1994, GlaxoSmithKline has contributed almost $23 million in humanitarian product donations.
  
  

• The GlaxoSmithKline Foundation supports employees who are personally committed to improving their communities by matching employee donations and/or providing a grant to charitable organizations where employees volunteer their time.
  
  

• Through the Community Innovation Program (in partnership with Shire BioChem), GlaxoSmithKline annually supports various HIV/AIDS community-based organizations that provide outreach and address barriers to treatment, thereby improving access to care for people living with HIV/AIDS across the country.
  
  

• GlaxoSmithKline and its employees provide more than $250,000 annually to United Way/Centraide campaigns in support of local community efforts.
  
  

• The GlaxoSmithKline Foundation also provides funding to organizations that encourage the interest and participation of young Canadians in science education, including:

~    ACTUA, a national organization that reaches more than 225,000 youth through interactive science camps, in-school programs and mentoring programs; and.

~    Canadian Biology Olympiad, a training and coaching program designed to help Canadian science students to progress to international competition.

 

COMMUNITY INVESTMENTS

• GSK is committed to working with patient groups at the highest levels of transparency and ethical standards.
  
  

• Community partners include: United Way and Centraide, Canadian Hospice Palliative Care Association, Asthma Society of Canada, Canadian Diabetes Association, Canadian Lung Association, Canadian Breast Cancer Network, National Ovarian Cancer Association and Lymphoma Foundation Canada.  

 

GLOBAL COMMITMENTS

• In 2007, GlaxoSmithKline donated more than $564 million to charitable initiatives in the global community. This equates to 3.8 per cent of our global pre-tax profits and places us among the leaders in charitable giving.
  
  

• GlaxoSmithKline has long been active in the struggle for improved health care in the developing world through several innovative, long-term programs.
  
  

• Internationally, GSK is the only pharmaceutical company conducting research and development into both the prevention and treatment of all three of the World Health Organization’s (WHO) priority diseases — HIV/AIDS, malaria and tuberculosis.

 

• In 2007, 150 million albendazole tablets, a preventative drug for the disfiguring tropical disease lymphatic filariasis (or elephantiasis), were donated to help eliminate the disease. Since 1992, approximately 750 million tablets have been donated, reaching over 130 million people.
  
  

• GlaxoSmithKline’s Africa Malaria Partnership supports three programs in eight African countries to reduce the impact of malaria through better prevention and treatment in partnership with Freedom from Hunger, AMREF (African Medical and Research Foundation) and Plan International.

 

• Positive Action, GlaxoSmithKline’s long-term international program of HIV education and care, supports 43 international programs in 36 countries for people living with HIV/AIDS.

 

For further information, please contact:
Community Partnerships and Philanthropy
GlaxoSmithKline Inc.
Tel: 905 819-3000
www.gsk.ca